Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
A genitourinary oncologist discusses the role of multidisciplinary care in the treatment of patients with advanced renal cell carcinoma.
There has been a 17% rise in cases since 2003 meaning the numbers are now at an all-time high
During a Case-Based Roundtable® event, Rana McKay, MD, discussed the updated favorable-risk group data for 4 frontline combination trials in renal cell carcinoma in the first article of a 2-part series.
Pedro Barata, MD, MSc, prompts the panel to share their opinions on which of the discussed clinical trials they find most promising and likely to influence clinical practice in the treatment of renal cell carcinoma.
Although smoking rates in the UK are going down, a growing population means there are still about 6.4 million smokers in the UK.
Laurence Albigès, MD, PhD, discusses the potential predictive and prognostic value of circulating KIM-1 in patients with renal cell carcinoma.
This announcement comes on the heels of an FDA acceptance of an investigational new drug application for ADI-270 in June.
Thousands of genetic mutations that could increase your risk of cancer have been identified in a startling new study behind the malfunction of the “tumour protection gene” BAP1
AbstractBackgroundThe development of immune checkpoint blockade (ICB) has revolutionized the clinical outcome of renal cell carcinoma (RCC).
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 ...
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.